A detailed history of Axq Capital, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Axq Capital, LP holds 3,304 shares of LLY stock, worth $2.49 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
3,304
Holding current value
$2.49 Million
% of portfolio
0.88%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $2.55 Million - $3.17 Million
3,304 New
3,304 $2.93 Billion
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $1.48 Million - $2.04 Million
3,400 New
3,400 $1.83 Billion
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $310,630 - $364,820
1,000 New
1,000 $343 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.